Targeting Adenosine Signaling in Parkinson's Disease: From Pharmacological to Non-pharmacological Approaches

Parkinson's disease (PD) is one of the most prevalent neurodegenerative disease displaying negative impacts on both the health and social ability of patients and considerable economical costs. The classical anti-parkinsonian drugs based in dopaminergic replacement are the standard treatment, bu...

Descripción completa

Detalles Bibliográficos
Autores principales: Nazario, Luiza R., da Silva, Rosane S., Bonan, Carla D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703841/
https://www.ncbi.nlm.nih.gov/pubmed/29217998
http://dx.doi.org/10.3389/fnins.2017.00658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703841/
https://www.ncbi.nlm.nih.gov/pubmed/29217998
http://dx.doi.org/10.3389/fnins.2017.00658

Ejemplares similares